• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫上皮样平滑肌肉瘤:大型机构系列中基于现代结果的诊断标准评估

Epithelioid Leiomyosarcoma of the Uterus: Modern Outcome-based Appraisal of Diagnostic Criteria in a Large Institutional Series.

作者信息

Chapel David B, Nucci Marisa R, Quade Bradley J, Parra-Herran Carlos

机构信息

Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital-Harvard Medical School, Boston, MA.

Department of Pathology, University of Michigan-Michigan Medicine, Ann Arbor, MI.

出版信息

Am J Surg Pathol. 2022 Apr 1;46(4):464-475. doi: 10.1097/PAS.0000000000001795.

DOI:10.1097/PAS.0000000000001795
PMID:34419987
Abstract

Epithelioid leiomyosarcoma of the uterus is rare and poorly understood. Herein, we characterize a large institutional series of epithelioid leiomyosarcomas aiming to define outcome-determinant diagnostic pathologic features. We also retrieved epithelioid smooth muscle tumors of unknown malignant potential and evaluated a consecutive cohort of leiomyomas for epithelioid subtypes. Of a total of 1177 uterine leiomyosarcomas, 81 (7%) were categorized as epithelioid after review. Epithelioid leiomyosarcoma was strictly defined as having round to polygonal cells with visible pink cytoplasm and round to ovoid nuclei in ≥50% of the tumor volume. Average age was 55 years (range: 26 to 81 y). Median tumor size was 11 cm; tumor was >5 cm in 93% of subjects; 47% were stage 1 at presentation. An infiltrative tumor border was observed, grossly and/or microscopically, in 89% of cases; necrosis was noted in 80%, and vascular invasion in 47%. Mitotic count in 2.4 mm2 (totalling 10 high-power fields, each field 0.55 mm in diameter) ranged from 3 to 100 (median: 26). All cases had moderate, severe or highly pleomorphic atypia. All cases had 2 or 3 of the following: necrosis, at least moderate atypia and ≥4 mitoses in 2.4 mm2. Immunohistochemistry revealed frequent expression of smooth muscle markers including SMA (96%), desmin (95%), and caldesmon (81%). HMB45 and Melan-A were negative in 92% and 100% of cases, respectively. Estrogen and progesterone receptors were expressed by 65% and 54% of tumors, respectively. Follow-up information was available in 68 subjects (median: 23 mo, range: 1 to 254); cancer-related death occurred in 63%, and an additional 15% had recurrent or metastatic disease at last follow-up. Disease-specific survival was shorter in epithelioid leiomyosarcoma patients (median: 44  mo; 35% at 5-y) than in a matched cohort of nonepithelioid leiomyosarcoma (median: 55 mo; 46% at 5-y) (P=0.03). Three epithelioid smooth muscle tumors of unknown malignant potential were evaluated, all <5 cm in size and with atypia and/or irregular borders but mitotic count below the threshold for malignancy. Two of these had follow-up available, which was uneventful. Of 142 consecutive leiomyomas assessed, none had epithelioid morphology as defined. Epithelioid leiomyosarcoma is an aggressive neoplasm, sometimes with a remarkably low mitotic count. In the setting of an epithelioid smooth muscle tumor of the uterus, we postulate that the diagnosis of malignancy is made in the presence of ≥2 of the following: moderate or severe atypia, ≥4 mitoses/2.4 mm2 and tumor cell necrosis. In their absence, the finding of tumor size ≥5 cm, vascular invasion, infiltrative edges or atypical mitoses should be treated with caution, and designation as of at least uncertain malignant potential is warranted.

摘要

子宫上皮样平滑肌肉瘤罕见且了解甚少。在此,我们对大量来自机构的上皮样平滑肌肉瘤病例进行特征分析,旨在明确决定预后的诊断性病理特征。我们还检索了具有未知恶性潜能的上皮样平滑肌肿瘤,并评估了一组连续的平滑肌瘤中的上皮样亚型。在总共1177例子宫平滑肌肉瘤中,经复查后有81例(7%)被归类为上皮样。上皮样平滑肌肉瘤被严格定义为在肿瘤体积的≥50%中具有圆形至多边形细胞,细胞质可见粉红色,核圆形至卵圆形。平均年龄为55岁(范围:26至81岁)。肿瘤中位数大小为11cm;93%的患者肿瘤>5cm;47%的患者初诊时为1期。89%的病例在大体和/或显微镜下观察到浸润性肿瘤边界;80%的病例有坏死,47%的病例有血管侵犯。每2.4mm²(总计10个高倍视野,每个视野直径0.55mm)的有丝分裂计数范围为3至100(中位数:26)。所有病例均有中度、重度或高度多形性异型性。所有病例均具备以下2项或3项:坏死、至少中度异型性以及每2.4mm²≥4个有丝分裂。免疫组化显示平滑肌标志物频繁表达,包括平滑肌肌动蛋白(SMA,96%)、结蛋白(95%)和钙调蛋白(81%)。HMB45和Melan - A分别在92%和100%的病例中呈阴性。65%的肿瘤表达雌激素受体,54%的肿瘤表达孕激素受体。68例患者有随访信息(中位数:23个月,范围:1至254个月);63%的患者发生癌症相关死亡,另有15%的患者在最后随访时出现复发或转移性疾病。上皮样平滑肌肉瘤患者的疾病特异性生存期较短(中位数:44个月;5年生存率35%),低于匹配的非上皮样平滑肌肉瘤队列(中位数:55个月;5年生存率46%)(P = 0.03)。评估了3例具有未知恶性潜能的上皮样平滑肌肿瘤,所有肿瘤大小均<5cm,有异型性和/或边界不规则,但有丝分裂计数低于恶性阈值。其中2例有随访信息,情况良好。在评估的142例连续平滑肌瘤中,无一例具有定义的上皮样形态。上皮样平滑肌肉瘤是一种侵袭性肿瘤,有时有丝分裂计数极低。对于子宫上皮样平滑肌肿瘤,我们推测在具备以下≥2项时可诊断为恶性:中度或重度异型性、每2.4mm²≥4个有丝分裂以及肿瘤细胞坏死。若不存在这些情况,对于肿瘤大小≥5cm、血管侵犯、浸润性边缘或非典型有丝分裂的发现应谨慎对待,至少指定为具有不确定的恶性潜能是合理的。

相似文献

1
Epithelioid Leiomyosarcoma of the Uterus: Modern Outcome-based Appraisal of Diagnostic Criteria in a Large Institutional Series.子宫上皮样平滑肌肉瘤:大型机构系列中基于现代结果的诊断标准评估
Am J Surg Pathol. 2022 Apr 1;46(4):464-475. doi: 10.1097/PAS.0000000000001795.
2
Inguinal smooth muscle tumors in women-a dichotomous group consisting of Müllerian-type leiomyomas and soft tissue leiomyosarcomas: an analysis of 55 cases.女性腹股沟平滑肌肉瘤——一种由 Müllerian 型平滑肌瘤和软组织平滑肌肉瘤组成的二分体:55 例分析。
Am J Surg Pathol. 2011 Mar;35(3):315-24. doi: 10.1097/PAS.0b013e318208e361.
3
Epithelioid smooth-muscle tumors of the uterus: a clinicopathologic study of 18 patients.子宫上皮样平滑肌瘤:18例患者的临床病理研究
Am J Surg Pathol. 1997 Apr;21(4):383-91. doi: 10.1097/00000478-199704000-00003.
4
Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases.膀胱平滑肌肿瘤:51 例临床病理研究。
Am J Surg Pathol. 2010 Apr;34(4):502-9. doi: 10.1097/PAS.0b013e3181cf326d.
5
Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms.子宫黏液样平滑肌肉瘤:30例临床病理分析及文献复习,并重新评估其与其他子宫黏液样间叶性肿瘤的鉴别诊断
Am J Surg Pathol. 2016 Mar;40(3):285-301. doi: 10.1097/PAS.0000000000000593.
6
Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma.膀胱平滑肌肿瘤:平滑肌瘤与平滑肌肉瘤的临床病理比较
Am J Surg Pathol. 2002 Mar;26(3):292-300. doi: 10.1097/00000478-200203000-00002.
7
Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy.具有非典型性的肾上皮样血管平滑肌脂肪瘤:40 例系列病例,重点在于恶性肿瘤的临床病理预后指标。
Am J Surg Pathol. 2010 May;34(5):715-22. doi: 10.1097/PAS.0b013e3181d90370.
8
Symplastic leiomyomas of the scrotum: a comparative study to usual leiomyomas and leiomyosarcomas.阴囊的共生型平滑肌瘤:与普通平滑肌瘤及平滑肌肉瘤的对比研究
Am J Surg Pathol. 2014 Oct;38(10):1410-7. doi: 10.1097/PAS.0000000000000228.
9
Retroperitoneal leiomyomas: a clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas.腹膜后平滑肌瘤:56例临床病理及免疫组化研究并与腹膜后平滑肌肉瘤对比
Am J Surg Pathol. 2001 Nov;25(11):1355-63. doi: 10.1097/00000478-200111000-00002.
10
Sinonasal smooth muscle cell tumors: a clinicopathologic and immunohistochemical analysis of 12 cases with emphasis on the low-grade end of the spectrum.鼻窦平滑肌细胞瘤:12例临床病理及免疫组化分析,重点关注谱系低端的低级别病变
Arch Pathol Lab Med. 2003 Mar;127(3):297-304. doi: 10.5858/2003-127-0297-SSMCT.

引用本文的文献

1
Primary Splenic Leiomyosarcoma With Metastasis in a Rhesus Monkey (Macaca mulatta).一只恒河猴(猕猴)发生的伴有转移的原发性脾平滑肌肉瘤
Vet Med Sci. 2025 May;11(3):e70378. doi: 10.1002/vms3.70378.
2
MG132 induces cell type‑specific anticancer effects in uterine leiomyosarcoma cell lines.MG132在子宫平滑肌肉瘤细胞系中诱导细胞类型特异性抗癌作用。
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13524. Epub 2025 Apr 11.
3
Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy.子宫平滑肌肉瘤的综合综述:发病机制、诊断、预后和靶向治疗。
Cells. 2024 Jun 26;13(13):1106. doi: 10.3390/cells13131106.
4
Combined Treatment of Uterine Leiomyosarcoma with Gamma Secretase Inhibitor MK-0752 and Chemotherapeutic Agents Decreases Cellular Invasion and Increases Apoptosis.γ-分泌酶抑制剂MK-0752与化疗药物联合治疗子宫平滑肌肉瘤可降低细胞侵袭并增加细胞凋亡。
Cancers (Basel). 2024 Jun 10;16(12):2184. doi: 10.3390/cancers16122184.
5
Uterine tumor resembling high-grade endometrial mesenchymal sarcoma with GATAD2B-MMRN1 fusion.伴有GATAD2B-MMRN1融合的类似高级别子宫内膜间叶肉瘤的子宫肿瘤。
Int J Clin Exp Pathol. 2023 Sep 15;16(9):252-258. eCollection 2023.
6
Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS).子宫肉瘤:西班牙肉瘤研究小组(GEIS)制定的诊断、治疗及随访临床实践指南
Ther Adv Med Oncol. 2023 Mar 28;15:17588359231157645. doi: 10.1177/17588359231157645. eCollection 2023.
7
Epithelioid Leiomyosarcoma of the Uterus and the Diagnostic Challenge in Diagnosing it on Small Biopsy.子宫上皮样平滑肌肉瘤及其小活检诊断中的挑战
J Midlife Health. 2022 Jul-Sep;13(3):241-243. doi: 10.4103/jmh.jmh_36_22. Epub 2023 Jan 14.
8
Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis.基于分子的子宫内膜间质肉瘤诊断免疫组化算法。
Mod Pathol. 2023 Apr;36(4):100084. doi: 10.1016/j.modpat.2022.100084. Epub 2023 Jan 10.